Cubbie Conference December 10, 2026 in San Francisco Get tickets →

Generative AI platform for de novo drug design that accelerates medicinal chemistry projects.

Pricing

Custom quote

Founded

2016

Team size

51-200 employees

Headquarters

Paris, France

About Iktos

Iktos applies generative AI and robotics to accelerate drug discovery. Its platform combines generative molecular design, AI-driven retrosynthesis planning, and automated lab systems into an integrated Design-Make-Test-Analyze cycle. It serves pharmaceutical and biotech R&D teams aiming to shorten discovery timelines.

Buyer Fit & Positioning

Procurement & Fit

Structured facts from the vendor to help your security, finance, and procurement reviews move faster.

Trust

Security & compliance

The vendor hasn’t added security or compliance details yet.

Pricing

Commercial model

Pricing model: Custom quote

Free trial: No

Free plan: No

Contract minimum: Not specified

Procurement

Purchasing & legal

The vendor hasn’t added purchasing & legal details yet.

Fit

Best-fit company size

Company-size fit has not been specified yet.

Implementation & Procurement

Commercial Fit & Ecosystem

Proof, Outcomes & Momentum

Alternatives, Migration & Buyer Objections